Health Canada has approved the updated version of the COVID-19 Comirnaty vaccine from Pfizer-BioNTech which targets the BA.4 and BA.5 subvariants of Omicron and whose use as a dose of booster is approved for people 12 years of age and older.
“Health Canada licensed this vaccine following a thorough and independent scientific review of the evidence, which demonstrated the safety and efficacy of this vaccine”, it was indicated in a press release on Friday.
According to the ministry, this new version of the Pfizer-BioNTech vaccine should present a similar safety profile to that of the original vaccine against COVID-19.
Recall that Moderna's bivalent vaccine has been available in Quebec since last month for protection against these same two variants.
Katrine Johns has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Gal Post, Katrine Johns worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my email@example.com 1-800-268-7128